The U.S. Preventive Services Task Force (USPSTF) strongly recommends that clinicians discuss the benefits and harms of aspirin therapy with healthy adult patients at increased risk of coronary heart disease, primarily heart attacks.
The USPSTF Recommendations and Rationale—as well as the Summary of Evidence, a press release, and fact sheets—are available below.
Tip: For information on accessing PDF Files, read PDF Help.
Return to U.S. Preventive Services Task Force
Clinical Information
AHRQ Home Page
Department of Health and Human Services